Feedback / Questions
CellProtect (evencaleucel) - Avaris, XNK Therap
Sarclisa (isatuximab-irfc) - Sanofi
https://www.prnewswire.com/news-releases/xnk-therapeutics-to-use-generic-name-evencaleucel-for-lead-candidate-301632786.html
Sep 26, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next